Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 117 Carcinoma, Transitional Cell 39 Testicular Neoplasms 23 Urethral Neoplasms 18 Testicular Germ Cell Tumor 14 Ovarian Neoplasms 13 Teratoma 12 Prostatic Neoplasms 11 Endodermal Sinus Tumor 11 Seminoma 10 Neoplasms 10 Carcinoma, Embryonal 9 Ureteral Neoplasms 8 Melanoma 8 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Renal Cell 7 Stomach Neoplasms 6 Penile Neoplasms 6 Neoplasm Metastasis 6 Colorectal Neoplasms 6 Breast Neoplasms 6 Urologic Neoplasms 5 Sarcoma 5 Pancreatic Neoplasms 5 Urothelial Cancer 4 Lung Neoplasms 4 Central Nervous System Neoplasms 4 Wilms Tumor 3 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3

Interventions

tislelizumab 1 pamiparib 1 TNFeraseBiologic 1 Injections 1 Gefitinib 1 Docetaxel 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Prostate Cancer × Cisplatin × Genitourinary × Clear all

NCT06387056 2024-04-26

SEGNO

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting

Locally Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡